Austria · Series B startup

Who invested in Hookipa Biotech

2 rounds we have observed, with the 5 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Funding summaryUpdated 26 Oct 2026

$35Mraised across 2 rounds since 2011, from 2 sources

$9.6MSeries A$26MSeries B
Latest round
Series B, $26MNov 2013
Step-upi
2.7×
Investors
5
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

20122013
$9.6MSeries A$26MSeries B
First round
Series A, $9.6M
Oct 2011
Biggest round
$26M
Series B · Nov 2013
Between rounds
2.1 years
from the last two

The rounds

  1. Nov 2013
  2. Oct 2011

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Everyone who backed them

Sofinnova PartnersVC firm2rounds
Forbion Capital PartnersPrivate equity2rounds
BioMedPartnersPrivate equity1round
Takeda VenturesCorporate VC1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Hookipa Biotech

Who invested in Hookipa Biotech?

Hookipa Biotech's investors include Sofinnova Partners, Forbion Capital Partners, Boehringer Ingelheim Venture Fund, BioMedPartners and Takeda Ventures.

How much has Hookipa Biotech raised?

Hookipa Biotech has raised $35M across 2 rounds since 2011.

When did Hookipa Biotech last raise?

Hookipa Biotech's most recent round was a Series B of $26M in Nov 2013.

What was Hookipa Biotech's biggest round?

Its most recent round, $26M in Nov 2013, is also its largest on record.

Who backed Hookipa Biotech first?

Hookipa Biotech's first round on record, in Oct 2011, was backed by Sofinnova Partners and Forbion Capital Partners.

What stage is Hookipa Biotech at?

Hookipa Biotech's latest named round is a Series B, in Nov 2013.

Where is Hookipa Biotech based?

Hookipa Biotech is based in Austria.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.